Episode

Healthcare AI Crosses the ROI Threshold: Inside Nvidia's 2026 State of AI in Healthcare Survey - June 30, 2026

Podcast
DX Today | No-Hype Podcast & News About AI & DX
Published
Jun 30, 2026
Duration seconds
767
Processing state
not_requested
Canonical source
https://www.buzzsprout.com/2207817/episodes/19423555-healthcare-ai-crosses-the-roi-threshold-inside-nvidia-s-2026-state-of-ai-in-healthcare-survey-june-30-2026.mp3
Audio
https://www.buzzsprout.com/2207817/episodes/19423555-healthcare-ai-crosses-the-roi-threshold-inside-nvidia-s-2026-state-of-ai-in-healthcare-survey-june-30-2026.mp3
JSON
/v1/public/podcasts/dx-today-no-hype-podcast-news-about-ai-dx-6434212/episodes/healthcare-ai-crosses-the-roi-threshold-inside-nvidia-s-2026-state-of-ai-in-healthcare-survey-june-30-2026
Markdown
/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212/healthcare-ai-crosses-the-roi-threshold-inside-nvidia-s-2026-state-of-ai-in-healthcare-survey-june-30-2026.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/dx-today-no-hype-podcast-news-about-ai-dx-6434212/episodes/healthcare-ai-crosses-the-roi-threshold-inside-nvidia-s-2026-state-of-ai-in-healthcare-survey-june-30-2026/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212/healthcare-ai-crosses-the-roi-threshold-inside-nvidia-s-2026-state-of-ai-in-healthcare-survey-june-30-2026.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Healthcare AI Crosses the ROI Threshold: Inside Nvidia's 2026 State of AI in Healthcare Survey Nvidia's second annual State of AI in Healthcare and Life Sciences survey signals that medical AI has finally moved from costly experimentation to measurable return on investment, with 70% of organizations now deploying AI, 85% reporting revenue gains, and 80% reporting cost reductions. Chris and Laura dig into where the money is actually showing up, from radiology turnaround times to drug discover...